BACKGROUND: Traumatic brain injury (TBI) involves several aspects of a patient's condition, including physical, mental, emotional, cognitive, social, and functional changes. Therefore, a clinical trial with individuals with TBI should consider outcome measures that reflect their global status. METHODS: We present the work of the National Institute of Child Health and Development-sponsored Traumatic Brain Injury Clinical Trials Network Outcome Measures subcommittee and its choice of outcome measures for a phase III clinical trial of patients with complicated mild to severe TBI. RESULTS: On the basis of theoretical and practical considerations, the subcommittee recommended the adoption of a core of 9 measures that cover 2 different areas of recovery: functional and cognitive. These measures are the Extended Glasgow Outcome Scale; the Controlled Oral Word Association Test; the Trail Making Test, Parts A and B; the California Verbal Learning Test-II; the Wechsler Adult Intelligence Scale-III Digit Span subtest; the Wechsler Adult Intelligence Scale-III Processing Speed Index; and the Stroop Color-Word Matching Test, Parts 1 and 2. CONCLUSIONS: The statistical methods proposed to analyze these measures using a global test procedure, along with research and methodological and regulatory issues involved with the use of multiple outcomes in a clinical trial, are discussed.
BACKGROUND:Traumatic brain injury (TBI) involves several aspects of a patient's condition, including physical, mental, emotional, cognitive, social, and functional changes. Therefore, a clinical trial with individuals with TBI should consider outcome measures that reflect their global status. METHODS: We present the work of the National Institute of Child Health and Development-sponsored Traumatic Brain Injury Clinical Trials Network Outcome Measures subcommittee and its choice of outcome measures for a phase III clinical trial of patients with complicated mild to severe TBI. RESULTS: On the basis of theoretical and practical considerations, the subcommittee recommended the adoption of a core of 9 measures that cover 2 different areas of recovery: functional and cognitive. These measures are the Extended Glasgow Outcome Scale; the Controlled Oral Word Association Test; the Trail Making Test, Parts A and B; the California Verbal Learning Test-II; the Wechsler Adult Intelligence Scale-III Digit Span subtest; the Wechsler Adult Intelligence Scale-III Processing Speed Index; and the Stroop Color-Word Matching Test, Parts 1 and 2. CONCLUSIONS: The statistical methods proposed to analyze these measures using a global test procedure, along with research and methodological and regulatory issues involved with the use of multiple outcomes in a clinical trial, are discussed.
Authors: N R Temkin; S S Dikmen; G D Anderson; A J Wilensky; M D Holmes; W Cohen; D W Newell; P Nelson; A Awan; H R Winn Journal: J Neurosurg Date: 1999-10 Impact factor: 5.115
Authors: S R Millis; M Rosenthal; T A Novack; M Sherer; T G Nick; J S Kreutzer; W M High; J H Ricker Journal: J Head Trauma Rehabil Date: 2001-08 Impact factor: 2.710
Authors: José León-Carrión; José María Dominguez-Roldán; Francisco Murillo-Cabezas; María del Rosario Dominguez-Morales; María Angeles Muñoz-Sanchez Journal: NeuroRehabilitation Date: 2000 Impact factor: 2.138
Authors: Nancy R Temkin; Gail D Anderson; H Richard Winn; Richard G Ellenbogen; Gavin W Britz; James Schuster; Timothy Lucas; David W Newell; Pamela Nelson Mansfield; Joan E Machamer; Jason Barber; Sureyya S Dikmen Journal: Lancet Neurol Date: 2007-01 Impact factor: 44.182
Authors: Mark Sherer; Thomas A Novack; Angelle M Sander; Margaret A Struchen; Amy Alderson; Risa Nakase Thompson Journal: Clin Neuropsychol Date: 2002-05 Impact factor: 3.535
Authors: G L Clifton; J S Kreutzer; S C Choi; C W Devany; H M Eisenberg; M A Foulkes; J A Jane; A Marmarou; L F Marshall Journal: Neurosurgery Date: 1993-07 Impact factor: 4.654
Authors: Jane L Mathias; Yasmin Harman-Smith; Stephen C Bowden; Jeffrey V Rosenfeld; Erin D Bigler Journal: J Neurotrauma Date: 2014-04-01 Impact factor: 5.269
Authors: Aziz S Alali; Darcy Vavrek; Jason Barber; Sureyya Dikmen; Avery B Nathens; Nancy R Temkin Journal: J Neurotrauma Date: 2015-02-09 Impact factor: 5.269
Authors: Jose-Miguel Yamal; H Julia Hannay; Shankar Gopinath; Imoigele P Aisiku; Julia S Benoit; Claudia S Robertson Journal: J Neurotrauma Date: 2019-05-23 Impact factor: 5.269
Authors: W Poon; C Matula; P E Vos; D F Muresanu; N von Steinbüchel; K von Wild; V Hömberg; E Wang; T M C Lee; S Strilciuc; J C Vester Journal: Neurol Sci Date: 2019-09-07 Impact factor: 3.307
Authors: Felicia C Goldstein; Angela F Caveney; Vicki S Hertzberg; Robert Silbergleit; Sharon D Yeatts; Yuko Y Palesch; Harvey S Levin; David W Wright Journal: J Neurotrauma Date: 2016-04-15 Impact factor: 5.269
Authors: Tessa Hart; Emma K T Benn; Emilia Bagiella; Patricia Arenth; Sureyya Dikmen; Dale C Hesdorffer; Thomas A Novack; Joseph H Ricker; Ross Zafonte Journal: J Neurotrauma Date: 2014-01-10 Impact factor: 5.269
Authors: Noah D Silverberg; Paul K Crane; Kristen Dams-O'Connor; James Holdnack; Brian J Ivins; Rael T Lange; Geoffrey T Manley; Michael McCrea; Grant L Iverson Journal: J Neurotrauma Date: 2016-06-27 Impact factor: 5.269